![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 90
2024
Gernert, Jonathan A. 
ORCID: https://orcid.org/0000-0002-6655-5557; Christmann, Tara; Kaufmann, Elisabeth ORCID: https://orcid.org/0000-0002-7582-2215; Delazer, Luisa ORCID: https://orcid.org/0009-0002-1330-3628; Kirsch, Isabel; Levin, Johannes ORCID: https://orcid.org/0000-0001-5092-4306; Schönecker, Sonja ORCID: https://orcid.org/0000-0003-4499-7861; Fietzek, Urban M.; Eulenburg, Peter zu; Velten, Theresa; Gripshi, Marina; Parhofer, Klaus G. ORCID: https://orcid.org/0000-0001-9873-0412; Maier, Esther M. ORCID: https://orcid.org/0000-0002-4954-4901; Kümpfel, Tania ORCID: https://orcid.org/0000-0001-7509-5268; Lotz-Havla, Amelie S. und Havla, Joachim ORCID: https://orcid.org/0000-0002-4386-1340
(2024):
Characterization of peripapillary hyperreflective ovoid mass-like structures (PHOMS) in a broad spectrum of neurological disorders.
In: Ophthalmology [Forthcoming]
ORCID: https://orcid.org/0000-0002-6655-5557; Christmann, Tara; Kaufmann, Elisabeth ORCID: https://orcid.org/0000-0002-7582-2215; Delazer, Luisa ORCID: https://orcid.org/0009-0002-1330-3628; Kirsch, Isabel; Levin, Johannes ORCID: https://orcid.org/0000-0001-5092-4306; Schönecker, Sonja ORCID: https://orcid.org/0000-0003-4499-7861; Fietzek, Urban M.; Eulenburg, Peter zu; Velten, Theresa; Gripshi, Marina; Parhofer, Klaus G. ORCID: https://orcid.org/0000-0001-9873-0412; Maier, Esther M. ORCID: https://orcid.org/0000-0002-4954-4901; Kümpfel, Tania ORCID: https://orcid.org/0000-0001-7509-5268; Lotz-Havla, Amelie S. und Havla, Joachim ORCID: https://orcid.org/0000-0002-4386-1340
(2024):
Characterization of peripapillary hyperreflective ovoid mass-like structures (PHOMS) in a broad spectrum of neurological disorders.
In: Ophthalmology [Forthcoming]
2023
Parhofer, Klaus G. ORCID: https://orcid.org/0000-0001-9873-0412
(2023):
Apheresis: What Should a Clinician Know?
In: Current Atherosclerosis Reports, Bd. 25, Nr. 3: S. 77-83
[PDF, 652kB]
ORCID: https://orcid.org/0000-0001-9873-0412
(2023):
Apheresis: What Should a Clinician Know?
In: Current Atherosclerosis Reports, Bd. 25, Nr. 3: S. 77-83
[PDF, 652kB]
Sapkota, Bhim Prasad ORCID: https://orcid.org/0000-0001-7104-5968; Baral, Kedar Prasad; Rehfuess, Eva A. ORCID: https://orcid.org/0000-0002-4318-8846; Parhofer, Klaus G. und Berger, Ursula ORCID: https://orcid.org/0000-0002-9809-4177
(2023):
Effects of age on non-communicable disease risk factors among Nepalese adults.
In: PLOS ONE 18(6), e0281028 [PDF, 805kB]
ORCID: https://orcid.org/0000-0001-7104-5968; Baral, Kedar Prasad; Rehfuess, Eva A. ORCID: https://orcid.org/0000-0002-4318-8846; Parhofer, Klaus G. und Berger, Ursula ORCID: https://orcid.org/0000-0002-9809-4177
(2023):
Effects of age on non-communicable disease risk factors among Nepalese adults.
In: PLOS ONE 18(6), e0281028 [PDF, 805kB]
2022
Merkel, MArtin; Müller-Wieland, Dirk; Laufs, Ulrich und Parhofer, Klaus G.
(2022):
Triglyzeride – Aktuelle Bewertung als Risikomarker und Therapieziele.
In: Deutsche Medizinische Wochenschrift, Bd. 147, Nr. 19: S. 1286-1294
Sapkota, Bhim Prasad ORCID: https://orcid.org/0000-0001-7104-5968; Baral, Kedar Prasad; Berger, Ursula; Parhofer, Klaus G. und Rehfuess, Eva A. ORCID: https://orcid.org/0000-0002-4318-8846
(2022):
Health sector readiness for the prevention and control of non-communicable diseases: A multi-method qualitative assessment in Nepal.
In: PLOS ONE 17(9), e0272361 [PDF, 737kB]
ORCID: https://orcid.org/0000-0001-7104-5968; Baral, Kedar Prasad; Berger, Ursula; Parhofer, Klaus G. und Rehfuess, Eva A. ORCID: https://orcid.org/0000-0002-4318-8846
(2022):
Health sector readiness for the prevention and control of non-communicable diseases: A multi-method qualitative assessment in Nepal.
In: PLOS ONE 17(9), e0272361 [PDF, 737kB]
Gitt, Anselm K.; Parhofer, Klaus G.; Laufs, Ulrich; Maerz, Winfried; Paar, W. Dieter; Bramlage, Peter und Marx, Nikolaus
(2022):
Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany.
In: Clinical Research in Cardiology, Bd. 112: S. 299-311
Laufs, Ulrich; Birkenfeld, Andreas L.; Fraass, Uwe; Hohenstein, Bernd; Siegert, Carsten; Klotsche, Jens; Steinhagen-Thiessen, Elisabeth; Pittrow, David; Dexl, Stefan; Salmen, Sunnhild; Schettler, Volker J. J. und Parhofer, Klaus G.
(2022):
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.
In: Cardiovascular Drugs and Therapy
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2022):
Lipidtherapie bei Patienten mit Diabetes mellitus.
In: Diabetologie, Bd. 18, Nr. 4: S. 412-417
Chapman, M. John; Zamorano, Jose L. und Parhofer, Klaus G.
(2022):
Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
In: Pharmacology & Therapeutics, Bd. 237, 108172
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2022):
Position Paper on Lipid Therapy in Patients with Diabetes Mellitus.
In: Experimental and Clinical Endocrinology & Diabetes, Bd. 130, Nr. SUPPL 1:
S117-S122
Pirmatova, Dilnoza; Dodkhoeva, Munavvara; Hasbargen, Uwe; Flemmer, Andreas W.; Abdusamatzoda, Zulfiya; Saburova, Khursheda; Salieva, Nasiba; Radzhabova, Surayyo und Parhofer, Klaus G.
(2022):
Screening for Gestational Diabetes Mellitus and Pregnancy Outcomes: Results from a Multicentric Study in Tajikistan.
In: Experimental and Clinical Endocrinology & Diabetes, Bd. 130, Nr. 12: S. 821-827
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2022):
Lipidtherapie bei Patienten mit Diabetes mellitus.
In: Diabetologie und Stoffwechsel, Bd. 17, Nr. Suppl 2:
S316-S322
Miller, Michael; Tokgozoglu, Lale; Parhofer, Klaus G.; Handelsman, Yehuda; Leiter, Lawrence A.; Landmesser, Ulf; Brinton, Eliot A. und Catapano, Alberico L.
(2022):
Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements.
In: Expert Review of Cardiovascular Therapy, Bd. 20, Nr. 8: S. 609-625
Parhofer, Klaus G.
(2022):
New targets for treating hypertriglyceridemia.
In: Current Opinion in Endocrinology Diabetes and Obesity, Bd. 29, Nr. 2: S. 106-111
Macicame, Ivalda; Katzmarzyk, Peter T.; Lauchande, Carlos; Uate, Jorge; Cavele, Nilzio; Manhica, Cremildo; Saathoff, Elmar; Parhofer, Klaus G. und Prista, Antonio
(2022):
Physical Activity Measured by Pedometer in a Peri-Urban Mozambican Population.
In: Journal of Physical Activity & Health, Bd. 19, Nr. 11: S. 777-785
Gitt, Anselm K.; Laufs, Ulrich; Marz, Winfried; Paar, W. Dieter; Bramlage, Peter; Marx, Nikolaus und Parhofer, Klaus G.
(2022):
Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia.
In: Journal of Clinical Medicine, Bd. 11, Nr. 13, 3810
2021
Lotz-Havla, Amelie S.; Weiß, Katharina; Schiergens, Katharina; Regenauer-Vandewiele, Stephanie; Parhofer, Klaus G.; Christmann, Tara; Böhm, Luise; Havla, Joachim und Maier, Esther M.
(10. Dezember 2021):
Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency.
In: Frontiers in Neurology, Bd. 12, 780624
[PDF, 8MB]
Aulinger, Benedikt A.; To Viet, Thuan; Waldmann, Elisa und Parhofer, Klaus G.
(2021):
Prevalence of the Metabolic Syndrome in Severely Obese Patients Presenting for Bariatric Surgery.
In: Digestive Diseases, Bd. 39, Nr. 4: S. 334-340
Macicame, Ivalda; Prista, António; Nhachungue, Sheila; Saathoff, Elmar; Rehfuess, Eva Annette; Parhofer, Klaus G.; Cavele, Nílzio und Manhiça, Cremildo
(2021):
Social determinants and behaviors associated with overweight and obesity among youth and adults in a peri-urban area of Maputo City, Mozambique.
In: Journal of Global Health, Bd. 11, Nr. 04021
[PDF, 1MB]
Parhofer, Klaus G.
(2021):
Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
In: Current atherosclerosis reports, Bd. 23, 74
[PDF, 753kB]
Folwaczny, Alexander; Waldmann, Elisa; Altenhofer, Julia; Henze, Kerstin und Parhofer, Klaus G.
(2021):
Postprandial Lipid Metabolism in Normolipidemic Subjects and Patients with Mild to Moderate Hypertriglyceridemia: Effects of Test Meals Containing Saturated Fatty Acids, Mono-Unsaturated Fatty Acids, or Medium-Chain Fatty Acids.
In: Nutrients, Bd. 13, Nr. 5, 1737
Lutjohann, Dieter; Stellaard, Frans; Boeluekbasi, Bediha; Kerksiek, Anja; Parhofer, Klaus G. und Laufs, Ulrich
(2021):
Anti-PCSK 9 antibodies increase the ratios of the brain-specific oxysterol 24S-hydroxycholesterol to cholesterol and to 27-hydroxycholesterol in the serum.
In: British Journal of Clinical Pharmacology, Bd. 87, Nr. 11: S. 4252-4261
Parhofer, Klaus G.
(2021):
Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
In: Current Atherosclerosis Reports, Bd. 23, Nr. 12, 74
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Mueller-Wieland, Dirk
(2021):
Lipidtherapie bei Patienten mit Diabetes mellitus. Eine gemeinsame Stellungnahme der Kommission Fettstoffwechsel sowie der AG Herz und Diabetes der Deutschen Diabetes Gesellschaft (DDG), der Sektion Diabetologie und Stoffwechsel der Deutschen Gesellschaft für Endokrinologie (DGE), der AG Herz und Diabetes der Deutschen Gesellschaft für Kardiologie (DGK) und der gemeinsamen AG Herz – Hormone – Diabetes der DGK, DGE und DDG.
In: Diabetologe, Bd. 17, Nr. 3: S. 293-298
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Mueller-Wieland, Dirk
(2021):
Lipidtherapie bei Patienten mit Diabetes mellitus – Eine gemeinsame Stellungnahme der Kommission Fettstoffwechsel sowie der AG Herz und Diabetes der Deutschen Diabetes Gesellschaft (DDG), der Sektion Diabetes, Adipositas und Stoffwechsel der Deutschen Gesellschaft für Endokrinologie (DGE), der AG Herz und Diabetes der Deutschen Gesellschaft für Kardiologie (DGK) und der gemeinsamen AG Herz – Hormone – Diabetes der DGK, DGE und DDG.
In: Diabetologie und Stoffwechsel, Bd. 16:
S312-S318
2020
Chigbu, Chibuike Ogwuegbu; Berger, Ursula; Aniebue, Uzochukwu U. und Parhofer, Klaus G.
(2. Dezember 2020):
Physical Activity and Outdoor Leisure Time Physical Exercise: A Population Study of Correlates and Hindrances in a Resource-Constrained African Setting.
In: Journal of Multidisciplinary Healthcare, Bd. 2020, Nr. 13: S. 1791-1799
[PDF, 314kB]
Georgakis, Marios K.; Malik, Rainer; Anderson, Christopher D.; Parhofer, Klaus G.; Hopewell, Jemma C. und Dichgans, Martin ORCID: https://orcid.org/0000-0002-0654-387X
(1. Februar 2020):
Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.
In: Brain, Bd. 143, Nr. 2: S. 597-610
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-0654-387X
(1. Februar 2020):
Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.
In: Brain, Bd. 143, Nr. 2: S. 597-610
[PDF, 1MB]
Laufs, Ulrich; Parhofer, Klaus G.; Ginsberg, Henry N. und Hegele, Robert A.
(2020):
Clinical review on triglycerides.
In: European Heart Journal, Bd. 41, Nr. 1: S. 99-109
Hegele, Robert A.; Boren, Jan; Ginsberg, Henry N.; Arca, Marcello; Averna, Maurizio; Binder, Christoph J.; Calabresi, Laura; Chapman, M. John; Cuchel, Marina; Eckardstein, Arnold von; Frikke-Schmidt, Ruth; Gaudet, Daniel; Hovingh, G. Kees; Kronenberg, Florian; Luetjohann, Dieter; Parhofer, Klaus G.; Raal, Frederick J.; Ray, Kausik K.; Remaley, Alan T.; Stock, Jane K.; Stroes, Erik S.; Tokgozoglu, Lale und Catapano, Alberico L.
(2020):
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement.
In: Lancet Diabetes & Endocrinology, Bd. 8, Nr. 1: S. 50-67
Klimek, Annemarie; Baerwald, Christoph; Schwarz, Martin; Rutsch, Frank; Parhofer, Klaus G.; Plöckinger, Ursula; Heddrich-Ellerbrok, Margret; Vom Dahl, Stephan; Schöne, Klaus; Ott, Markus; Lang, Frauke und Hennermann, Julia B.
(2020):
Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study.
In: Annals of Nutrition and Metabolism, Bd. 76, Nr. 4: S. 251-258
Aulinger, Benedikt A.; Perabo, Marta; Seeley, Randy J.; Parhofer, Klaus G. und D'Alessio, David A.
(2020):
Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats.
In: American Journal of Physiology-Endocrinology and Metabolism, Bd. 318, Nr. 2, E189-E197
Parhofer, Klaus G.; Chapman, M. John und Nordestgaard, Borge G.
(2020):
Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap.
In: European Heart Journal Supplements, Bd. 22, Nr. J:
J21-J33
2019
Chigbu, Chibuike Ogwuegbu; Aniebue, Uzochukwu U.; Berger, Ursula und Parhofer, Klaus G.
(März 2019):
Impact of perceptions of body size on obesity and weight management behaviour: a large representative population study in an African setting.
In: Journal of Public Health, Bd. 43, Nr. 1, e54-e61
Ma, Louis; Waldmann, Elisa; Ooi, Esther M. M.; Chan, Dick C.; Barrett, Hugh P. R.; Watts, Gerald F. und Parhofer, Klaus G.
(2019):
Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
In: European Journal of Clinical Investigation, Bd. 49, Nr. 2, UNSP e13053
Parhofer, Klaus G. und Laufs, Ulrich
(2019):
The Diagnosis and Treatment of Hypertriglyceridemia.
In: Deutsches Ärzteblatt International, Bd. 116, Nr. 49
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2019):
Position Paper on Lipid Therapy in Patients with Diabetes Mellitus.
In: Experimental and Clinical Endocrinology & Diabetes, Bd. 127:
S97-S101
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2019):
Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus.
In: Diabetologie und Stoffwechsel, Bd. 14:
S226-S231
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2019):
Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus. Eine gemeinsame Stellungnahme der Kommission Fettstoffwechsel sowie der AG Herz und Diabetes der Deutschen Diabetes Gesellschaft (DDG), der Sektion Diabetologie und Stoffwechsel der Deutschen Gesellschaft für Endokrinologie (DGE), der AG Herz und Diabetes der Deutschen Gesellschaft für Kardiologie (DGK) und der gemeinsamen AG Herz – Hormone – Diabetes der DGK, DGE und DDG.
In: Diabetologe, Bd. 15, Nr. 5: S. 432-436
Waldmann, Elisa und Parhofer, Klaus G.
(2019):
Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).
In: Pathology, Bd. 51, Nr. 2: S. 227-232
Packer, Milton; Butler, Javed; Filippatos, Gerasimos S.; Jamal, Waheed; Salsali, Afshin; Schnee, Janet; Kimura, Karen; Zeller, Cordula; George, Jyothis; Brueckmann, Martina; Anker, Stefan D.; Zannad, Faiez; Perrone, Sergio; Nicholls, Stephen; Janssens, Stefan; Bocchi, Edmar; Giannetti, Nadia; Verma, Subodh; Jian, Zhang; Spinar, Jindrich; Seronde, Marie-France; Boehm, Michael; Merkely, Bela; Chopra, Vijay; Senni, Michele; Taddei, Stefano; Tsutsui, Hiroyuki; Choi, Dong-Ju; Chuquiure, Eduardo; La Rocca, Hans Pieter Brunner; Ponikowski, Piotr; Gonzalez Juanatey, Jose Ramon; Squire, Iain; Butler, Javed; Januzzi, James; Pina, Ileana; Pocock, Stuart J.; Carson, Peter; Doehner, Wolfram; Miller, Alan; Haas, Markus; Pehrson, Steen; Komajda, Michel; Anand, Inder; Teerlink, John; Rabinstein, Alejandro; Steiner, Thorsten; Kamel, Hooman; Tsivgoulis, Georgios; Lewis, James; Freston, James; Kaplowitz, Neil; Mann, Johannes; Petrie, Mark; Bernstein, Richard; Cheung, Alfred; Green, Jennifer; Januzzi, James; Kaul, Sanjay; Ping, Carolyn Lam Su; Lip, Gregory; Marx, Nikolaus; McCullough, Peter; Mehta, Cyrus; Ponikowski, Piotr; Rosenstock, Julio; Sattar, Naveed; Scirica, Benjamin; Tsutsui, Hiroyuki; Verma, Subodh; Wanner, Christoph; Welty, Francine K.; Parhofer, Klaus G.; Clayton, Tim; Pedersen, Terje R.; Lees, Kennedy R.; Konstam, Marvin A.; Greenberg, Barry und Palmer, Mike
(2019):
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial.
In: European Journal of Heart Failure, Bd. 21, Nr. 10: S. 1270-1278
Thompson, Gilbert und Parhofer, Klaus G.
(2019):
Current Role of Lipoprotein Apheresis.
In: Current Atherosclerosis Reports, Bd. 21, Nr. 7, 26
2018
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2018):
Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus.
In: Diabetologie und Stoffwechsel, Bd. 13, Nr. Suppl. 2:
S209-S213
Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk
(2018):
Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus.
In: Aktuelle Kardiologie, Bd. 7, Nr. 6: S. 431-435
Siegrist, Monika; Hanssen, Henner; Lammel, Christoph; Haller, Bernhard; Koch, Anna-Maria; Stemp, Pia; Dandl, Elke; Liestak, Roberta; Parhofer, Klaus G.; Vogeser, Michael und Halle, Martin
(2018):
Effects of a cluster-randomized school-based prevention program on physical activity and microvascular function (JuvenTUM 3).
In: Atherosclerosis, Bd. 278: S. 73-81
Bradley, Clare; Eschwege, Eveline; Pablos-Velasco, Pedro de; Parhofer, Klaus G.; Simon, Dominique; Vandenberghe, Hans und Gonder-Frederick, Linda
(2018):
Predictors of Quality of Life and Other Patient-Reported Outcomes in the PANORAMA Multinational Study of People With Type 2 Diabetes.
In: Diabetes Care, Bd. 41, Nr. 2: S. 267-276
Parhofer, Klaus G.
(2018):
Controversial Issues In The Treatment Of Dyslipidemias In Patients With Diabetes Mellitus.
In: Revista De Investigacion Clinica-Clinical and Translational Investigation, Bd. 70, Nr. 5: S. 237-243
Bamberger, Charlotte; Rossmeier, Andreas; Lechner, Katharina; Wu, Liya; Waldmann, Elisa; Fischer, Sandra; Stark, Renee G.; Altenhofer, Julia; Henze, Kerstin und Parhofer, Klaus G.
(2018):
A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial.
In: Nutrients, Bd. 10, Nr. 2, 244
[PDF, 2MB]
Müller-Wieland, Dirk und Parhofer, Klaus G.
(2018):
Medikamentöse Therapie von Fettstoffwechselstörungen bei Patienten mit Typ-2-Diabetes.
In: Diabetologie und Stoffwechsel, Bd. 13, Nr. 5: S. 403-422
Schmidt, Nina; Dressel, Alexander; Grammer, Tanja B.; Gouni-Berthold, Ioanna; Julius, Ulrich; Kassner, Ursula; Klose, Gerald; König, Christel; König, Wolfgang; Otte, Britta; Parhofer, Klaus G.; Reinhard, Wibke; Schatz, Ulrike; Schunkert, Heribert; Steinhagen-Thiessen, Elisabeth; Vogt, Anja; Laufs, Ulrich und März, Winfried
(2018):
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
In: Atherosclerosis, Bd. 277: S. 314-322
Waldmann, Elisa; Vogt, Anja; Crispin, Alexander; Altenhofer, Julia; Riks, Ina und Parhofer, Klaus G.
(2018):
Corrigendum to: “Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)” [Atherosclerosis 259 (2017 Apr) 20–25].
In: Atherosclerosis, Bd. 275: S. 461-462
Chigbu, Chibuike Ogwuegbu; Parhofer, Klaus G.; Aniebue, Uzochukwu U. und Berger, Ursula
(2018):
Prevalence and sociodemographic determinants of adult obesity: A large representative household survey in a resource-constrained African setting with double burden of undernutrition and overnutrition.
In: Journal of epidemiology and community health
[PDF, 183kB]
2017
Waldmann, Elisa; Vogt, Anja; Crispin, Alexander; Altenhofer, Julia; Riks, Ina und Parhofer, Klaus G.
(2017):
Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
In: Atherosclerosis, Bd. 259: S. 20-25
Waldmann, Elisa; Bamberger, Charlotte und Parhofer, Klaus G.
(2017):
Statin intolerance is the main indication for PCSK9 inhibition in clinical practice.
In: Atherosclerosis, Bd. 263, E80-E80
Parhofer, Klaus G.
(2017):
New approaches to address dyslipidemia.
In: Current Opinion in Lipidology, Bd. 28, Nr. 6: S. 452-457
Dichgans, Martin; Böhm, Michael; Diener, Hans-Christoph; Hamann, Gerhard F.; Herbst, Heinz-Peter; Minnerup, Jens; Parhofer, Klaus G.; Petzold, Gabor; Schmidtke, Klaus und Zerr, Inga
(2017):
Vaskuläre Demenzen.
In: Aktuelle Neurologie, Bd. 44, Nr. 5: S. 299-311
Kahnert, Kathrin ORCID: https://orcid.org/0000-0001-9633-3368; Lucke, Tanja; Huber, Rudolf M.; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Biertz, Frank; Vogt, Anja; Watz, Henrik; Alter, Peter; Fähndrich, Sebastian; Bals, Robert; Holle, Rolf; Karrasch, Stefan ORCID: https://orcid.org/0000-0001-9807-2915; Sohler, Sandra; Wacker, Margarethe; Ficker, Joachim H.; Parhofer, Klaus G.; Vogelmeier, Claus und Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117
(2017):
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
In: PLOS One 12(5), e0177501 [PDF, 4MB]
ORCID: https://orcid.org/0000-0001-9633-3368; Lucke, Tanja; Huber, Rudolf M.; Behr, Jürgen ORCID: https://orcid.org/0000-0002-9151-4829; Biertz, Frank; Vogt, Anja; Watz, Henrik; Alter, Peter; Fähndrich, Sebastian; Bals, Robert; Holle, Rolf; Karrasch, Stefan ORCID: https://orcid.org/0000-0001-9807-2915; Sohler, Sandra; Wacker, Margarethe; Ficker, Joachim H.; Parhofer, Klaus G.; Vogelmeier, Claus und Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117
(2017):
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
In: PLOS One 12(5), e0177501 [PDF, 4MB]
März, Winfried; Kleber, Marcus E.; Scharnagl, Hubert; Speer, Timotheus; Zewinger, Stephen; Ritsch, Andreas; Parhofer, Klaus G.; Eckardstein, Arnold von; Landmesser, Ulf und Laufs, Ulrich
(2017):
HDL cholesterol: reappraisal of its clinical relevance.
In: Clinical Research in Cardiology, Bd. 106, Nr. 9: S. 663-675
Stroes, Erik; Moulin, Philippe; Parhofer, Klaus G.; Rebours, Vinciane; Löhr, J.-Matthias und Averna, Maurizio
(2017):
Diagnostic algorithm for familial chylomicronemia syndrome.
In: Atherosclerosis Supplements, Bd. 23: S. 1-7
Bamberger, Charlotte; Rossmeier, Andreas; Lechner, Katharina; Wu, Liya; Waldmann, Elisa; Stark, Renee G.; Altenhofer, Julia; Henze, Kerstin und Parhofer, Klaus G.
(2017):
A Walnut-Enriched Diet Reduces Lipids in Healthy Caucasian Subjects, Independent of Recommended Macronutrient Replacement and Time Point of Consumption: A Prospective, Randomized, Controlled Trial.
In: Nutrients, Bd. 9, Nr. 10, 1097
[PDF, 1MB]
2016
Bertheau, Robert C.; Bamberg, Fabian; Lochner, Elena; Findeisen, Hannes M.; Parhofer, Klaus G.; Kauczor, Hans-Ulrich; Schoenberg, Stefan O.; Weckbach, Sabine und Schlett, Christopher L.
(2016):
Whole-Body MR Imaging Including Angiography: Predicting Recurrent Events in Diabetics.
In: European Radiology, Bd. 26, Nr. 5: S. 1420-1430
Moriarty, Patrick M.; Parhofer, Klaus G.; Babirak, Stephan P.; Cornier, Marc-Andre; Duell, P. Barton; Hohenstein, Bernd; Leebmann, Josef; Ramlow, Wolfgang; Schettler, Volker; Simha, Vinaya; Steinhagen-Thiessen, Elisabeth; Thompson, Paul D.; Vogt, Anja; Stritzky, Berndt von; Du, Yunling und Manvelian, Garen
(2016):
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial.
In: European Heart Journal, Bd. 37, Nr. 48: S. 3588-3595
Hooper, Amanda J.; Robertson, Ken; Champain, Danie; Hua, Jianmin; Song, Swithin; Parhofer, Klaus G.; Barrett, P. Hugh R.; Bockxmeer, Frank M. van und Burnett, John R.
(2016):
Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
In: Clinical Biochemistry, Bd. 49, Nr. 9: S. 720-722
El Khoury, Petra; Waldmann, Elisa; Huby, Thierry; Gall, Julie; Couvert, Philippe; Lacorte, Jean-Marc; Chapman, John; Frisdal, Eric; Lesnik, Philippe; Parhofer, Klaus G.; Le Goff, Wilfried und Guerin, Maryse
(2016):
Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.
In: Arteriosclerosis thrombosis and Vascular Biology, Bd. 36, Nr. 2: S. 285-294
Moriarty, Patrick M.; Parhofer, Klaus G.; Babirak, Stephan P.; deGoma, Emil; Duell, P. Barton; Hohenstein, Bernd; Ramlow, Wolfgang; Simha, Vinaya; Steinhagen-Thiessen, Elisabeth; Thompson, Paul D.; Vogt, Anja; Stritzky, Berndt von; Du, Yunling und Manvelian, Garen
(2016):
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial.
In: Journal of Clinical Lipidology, Bd. 10, Nr. 3: S. 627-634
Parhofer, Klaus G.
(2016):
Too Many Competing Interests Reply.
In: Deutsches Ärzteblatt international, Bd. 113, Nr. 38: S. 643-644
Parhofer, Klaus G.
(2016):
The Treatment of Disorders of Lipid Metabolism.
In: Deutsches Ärzteblatt international, Bd. 113, Nr. 15: S. 261-268
Waldmann, Elisa und Parhofer, Klaus G.
(2016):
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Lipoprotein apheresis to treat elevated lipoprotein (a).
In: Journal of Lipid Research, Bd. 57, Nr. 10: S. 1751-1757
Lebherz, Corinna; Kahles, Florian; Piotrowski, Katja; Vogeser, Michael; Foldenauer, Ann Christina; Nassau, Kirsten; Kilger, Erich; Marx, Nikolaus; Parhofer, Klaus G. und Lehrke, Michael
(2016):
Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism.
In: Cardiovascular Diabetology
15:21
[PDF, 843kB]
2015
Fugmann, Marina; Uhl, Olaf; Hellmuth, Christian; Hetterich, Holger; Kammer, Nora N.; Ferrari, Uta; Parhofer, Klaus G.; Koletzko, Berthold; Seissler, Jochen und Lechner, Andreas
(2015):
Differences in the Serum Nonesterified Fatty Acid Profile of Young Women Associated with a Recent History of Gestational Diabetes and Overweight/Obesity.
In: PLOS ONE 10(5), e0128001 [PDF, 446kB]
In: PLOS ONE 10(5), e0128001 [PDF, 446kB]
Parhofer, Klaus G.
(2015):
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia.
In: Diabetes & Metabolism Journal, Bd. 39, Nr. 5: S. 353-362
Fugmann, Marina; Breier, Michaela; Rottenkolber, Marietta; Banning, Friederike; Ferrari, Uta; Sacco, Vanessa; Grallert, Harald; Parhofer, Klaus G.; Seissler, Jochen; Clavel, Thomas und Lechner, Andreas
(2015):
The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes.
In: Scientific Reports, Bd. 5, 13212
[PDF, 820kB]
Mola-Schenzle, E; Staffler, A.; Klemme, M.; Pellegrini, F.; Molinaro, G.; Parhofer, Klaus G.; Messner, H.; Schulze, Andreas und Flemmer, A. W.
(2015):
Clinically stable very low birthweight infants are at risk for recurrent tissue glucose fluctuations even after fully established enteral nutrition.
In: Archives of disease in childhood - Fetal and neonatal edition, Bd. 100, Nr. 2:
F126-F131
[PDF, 1MB]
2014
Wu, Liya; Piotrowski, Katja; Rau, Tiina; Waldmann, Elisa; Broedl, Uli C.; Demmelmair, Hans; Koletzko, Berthold; Stark, Renee G.; Nagel, Jutta M.; Mantzoros, Christos S. und Parhofer, Klaus G.
(2014):
Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.
In: Metabolism: clinical and experimental, Bd. 63, Nr. 3: S. 382-391
Watts, Gerald F.; Gidding, Samuel; Wierzbicki, Anthony S.; Toth, Peter P.; Alonso, Rodrigo; Brown, W. Virgil; Bruckert, Eric; Defesche, Joep; Lin, Khoo Kah; Livingston, Michael; Mata, Pedro; Parhofer, Klaus G.; Raal, Frederick J.; Santos, Raul D.; Sijbrands, Eric J. G.; Simpson, William G.; Sullivan, David R.; Susekov, Andrey V.; Tomlinson, Brian; Wiegman, Albert; Yamashita, Shizuya und Kastelein, John J. P.
(2014):
Integrated Guidance on the Care of Familial Hypercholesterolaemia from the International FH Foundation: Executive Summary.
In: European Journal of Preventive Cardiology, Bd. 22, Nr. 7: S. 849-854
[PDF, 136kB]
Navti, Lifoter K.; Ferrari, Uta; Tange, Emmanuel; Bechtold-Dalla Pozza, Susanne und Parhofer, Klaus G.
(2014):
Contribution of socioeconomic status, stature and birth weight to obesity in Sub-Saharan Africa: cross-sectional data from primary school-age children in Cameroon.
In: BMC Public Health
14:320
[PDF, 209kB]
2013
Piotrowski, Katja; Becker, Melanie; Zugwurst, Julia; Biller-Friedmann, Ingeborg; Spoettl, Gerald; Greif, Martin; Leber, Alexander W.; Becker, Alexander; Laubender, Rüdiger P.; Lebherz, Corinna; Göke, Burkhard; Marx, Nikolaus; Parhofer, Klaus G. und Lehrke, Michael
(2013):
Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans.
In: Cardiovascular Diabetology
12:117
[PDF, 178kB]
Waldmann, Elisa; Huettl, Thomas P.; Göke, Burkhard; Lang, Reinhold und Parhofer, Klaus G.
(2013):
Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients.
In: Lipids in Health and Disease
12:82
[PDF, 358kB]
2012
Horster, Sophia; Stemmler, H. Joachim; Mandel, Philipp C.; Mueck, Alexander; Tischer, Johanna; Hausmann, Andreas; Parhofer, Klaus G. und Geiger, Sandra
(2012):
Mortality of Patients with Hematological Malignancy after Admission to the Intensive Care Unit.
In: Onkologie, Nr. 10: S. 556-561
[PDF, 251kB]
Dames, Petra; Weise, Michaela; Puff, Ramona; Göke, Burkhard; Parhofer, Klaus G.; Seissler, Jochen und Lechner, Andreas
(2012):
Suppression of the Nuclear Factor Eny2 Increases Insulin Secretion in Poorly Functioning INS-1E Insulinoma Cells.
In: Experimental Diabetes Research, Bd. 2012, 460869
[PDF, 2MB]
2010
Findeisen, Hannes M.; Weckbach, Sabine; Stark, Renee G.; Reiser, Maximilian F.; Schoenberg, Stefan O. und Parhofer, Klaus G.
(2010):
Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus.
In: Cardiovascular Diabetology
9:44
[PDF, 450kB]
Dames, Petra; Puff, Ramona; Weise, Michaela; Parhofer, Klaus G.; Göke, Burkhard; Götz, Magdalena ORCID: https://orcid.org/0000-0003-1551-9203; Graw, Jochen; Favor, Jack und Lechner, Andreas
(2010):
Relative roles of the different Pax6 domains for pancreatic alpha cell development.
In: BMC Developmental Biology
10:39
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-1551-9203; Graw, Jochen; Favor, Jack und Lechner, Andreas
(2010):
Relative roles of the different Pax6 domains for pancreatic alpha cell development.
In: BMC Developmental Biology
10:39
[PDF, 2MB]
2009
Hartl, Wolfgang H.; Jauch, Karl-Walter; Parhofer, Klaus G. und Rittler, Peter
(2009):
Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11.
In: German medical science : GMS e-journal, Bd. 7:
Doc17
[PDF, 1MB]
Boeck, Stefan; Metzeler, Klaus H.; Hausmann, Andreas; Baumann, Anja; Gallmeier, Eike; Parhofer, Klaus G. und Stemmler, Hans-Joachim
(2009):
Cisplatin-Based Chemotherapy for Pulmonary Metastasized Germ Cell Tumors of the Testis - Be Aware of Acute Respiratory Distress Syndrome.
In: Onkologie, Nr. 3: S. 125-128
[PDF, 111kB]
Lehrke, Michael; Greif, Martin; Broedl, Uli C.; Lebherz, Corinna; Laubender, Rüdiger P.; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Steinbeck, Gerhard; Leber, Alexander W. und Parhofer, Klaus G.
(2009):
MMP-1 serum levels predict coronary atherosclerosis in humans.
In: Cardiovascular Diabetology
8:50
[PDF, 308kB]
Broedl, Uli C.; Lebherz, Corinna; Lehrke, Michael; Stark, Renee; Greif, Martin; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Parhofer, Klaus G. und Leber, Alexander W.
(2009):
Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.
In: PLOS ONE 4(3), e4733 [PDF, 112kB]
In: PLOS ONE 4(3), e4733 [PDF, 112kB]
2008
Lehrke, Michael; Broedl, Uli C.; Biller-Friedmann, Ingeborg M.; Vogeser, Michael; Henschel, Volkmar; Nassau, Kirsten; Goeke, Burkhard; Kilger, Erich und Parhofer, Klaus G.
(2008):
Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions.
In: Critical Care
12:R157
[PDF, 320kB]
Fraunberger, Peter; Holler, Ernst; Parhofer, Klaus G.; Walli, Autar K. und Seidel, Dietrich
(2008):
Haben die Konzentrationen von Interleukin 6, Procalcitonin und CRP bei Intensivpatienten während des ersten Fieberanstieges eine prognostische Bedeutung?
In: Laboratoriumsmedizin - Journal of Laboratory Medicine, Bd. 32, Nr. 6: S. 434-437
[PDF, 71kB]
2007
Parhofer, Klaus G.; Muenzel, Felix und Krekler, Michael
(2007):
Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study.
In: Cardiovascular Diabetology
6:36
[PDF, 253kB]
2006
Broedl, Uli C.; Lehrke, Michael; Fleischer-Brielmaier, Elisabeth; Tietz, Anne B.; Nagel, Jutta M.; Göke, Burkhard; Lohse, Peter und Parhofer, Klaus G.
(2006):
Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome.
In: Cardiovascular Diabetology
5:11
[PDF, 284kB]
2003
Empen, Klaus; Frost, Robert J. A.; Geiss, H. Christian; Otto, Carsten und Parhofer, Klaus G.
(2003):
Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial.
In: Cardiovascular Diabetology
2:17
[PDF, 260kB]